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Background: Both trauma-induced coagulopathy (TIC) and transfusion strategies influ-
ence early outcome in hemorrhagic trauma patients. Their impact on late outcome
is less well characterized. This study systematically reviews risk factors for TIC- and
transfusion-associated multiple organ failure (MOF) in severely injured trauma patients.
Materials and methods: A systematic search was conducted in PubMed and Embase.
Studies published from 1986 to 2013 on adult trauma patients with an injury severity score
≥16, investigating TIC or transfusion strategies with MOF as primary or secondary out-
come, were eligible for inclusion. Results of the included studies were evaluated with
meta-analyses of pooled data.
Results: In total, 50 studies were included with a total sample size of 63,586 patients. Due
to heterogeneity of the study populations and outcome measures, results from 7 studies
allowed for pooling of data. Risk factors for TIC-associated MOF were hypocoagulopathy,
hemorrhagic shock, activated protein C, increased histone levels, and increased levels of
markers of fibrinolysis on admission. After at least 24 h after admission, the occurrence of
thromboembolic events was associated with MOF. Risk factors for transfusion-associated
MOF were the administration of fluids and red blood cell units within 24 h post-injury, the
age of red blood cells (>14 days) and a ratio of FFP:RBC≥1:1 (OR 1.11, 95% CI 1.04–1.19).
Conclusion: Risk factors for TIC-associated MOF in severely injured trauma patients are
early hypocoagulopathy and hemorrhagic shock, while a hypercoagulable state with the
occurrence of thromboembolic events later in the course of trauma predisposes to MOF.
Risk factors for transfusion-associated MOF include administration of crystalloids and red
blood cells and a prolonged storage time of red blood cells. Future prospective studies
investigating TIC- and transfusion-associated risk factors on late outcome are required.
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INTRODUCTION
Despite advances in trauma care, multiple organ failure (MOF)
still remains one of the leading causes of late mortality (occurring
after more than 3 days) in trauma patients (1, 2). The incidence of
MOF in severely injured trauma patients ranges from 15% up until
40% (3–6), with an associated mortality rate that varies between
24% (3) and 51% (6). Even though MOF-related mortality has
been shown to decrease over the last decades (2, 6), mortality is
still 10 times higher in patients with MOF compared to patients
without MOF (4, 5).
Over the last decade, trauma-induced coagulopathy (TIC) is
increasingly recognized to contribute to adverse early outcome
Abbreviations: ED, emergency department; FFP, fresh frozen plasma; ISS, injury
severity score; MOF, multiple organ failure; RBC, red blood cell; RCT, randomized
controlled trial; rVII, recombinant factor VII; TIC, trauma-induced coagulopathy.
in trauma patients (7–13). In recognition of that, transfusion
strategies have changed toward more and earlier administration of
plasma. This has led to a shift in the ratio of RBC:FFP to 1:1. Fur-
thermore, fluid resuscitation with crystalloids has evolved from
aggressive therapy to a minimal amount of crystalloid admin-
istration. More and earlier administration of plasma, combined
with a restriction of crystalloid administration, has showed to
reduce early mortality (14–16). However, the impact of both
TIC and changing transfusion strategies on the occurrence of
MOF has not been systematically reviewed before. Therefore, the
aim of this study was to summarize risk factors for TIC- and
transfusion-associated MOF in severely injured trauma patients.
MATERIALS AND METHODS
The present study was reported according to the PRISMA
guidelines (preferred reporting items for systematic reviews and
meta-analyses) (17).
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STUDY SELECTION
An electronic search was conducted in PubMed and Embase
for articles published from 1986 to 2013. In addition, we
searched for ongoing trials on www.controlled-trials.com and
www.clinicaltrials.gov.
The following subject headings and free text words
were used: (“Blood Coagulation Disorders”[Mesh] OR “Blood
Coagulation”[Mesh] OR Coagulation[tiab] OR coagulopa-
thy[tiab] OR “Fibrinolysis”[Mesh] OR Fibrinolysis[tiab] OR
hypofibrinolysis[tiab] OR hyperfibrinolysis[tiab]) OR (“Blood
Transfusion”[Mesh] OR Transfusion[tiab] OR “Transfusion Med-
icine”[Mesh] OR “Erythrocyte Transfusion”[Mesh] OR “Blood
Component Transfusion”[Mesh]) AND (“Multiple Organ Fail-
ure”[Mesh] OR multiple organ failure*[tiab] OR MOF[tiab]
OR (infection*[tiab] AND trauma[tiab])) AND (“Multiple
Trauma”[Mesh] OR multiple trauma[tiab] OR “Wounds and
Injuries”[Mesh] OR “Injury Severity Score”[Mesh] OR Injury
Severity Score[tiab] OR ISS[tiab] (Table S2 in Supplementary
Material).
Target population were trauma patients who suffered blunt
or penetrating trauma, with a mean injury severity score (ISS)
of ≥16 and an age of ≥16 years. Randomized controlled trials
(RCTs) and observational studies investigating TIC or transfu-
sion strategies with MOF as primary or secondary outcome were
eligible for inclusion. Studies, which focused on patients with
isolated traumatic brain injury or burn injury, were excluded.
Both prospective and retrospective studies were included. Reviews,
correspondences, case reports, expert opinions, and editorials
were excluded. The search was conducted by two independent
researchers (Kirsten Balvers and Mathijs R. Wirtz). Any discrep-
ancies in the included studies were resolved by discussion between
the reviewers. If necessary, an independent third reviewer was con-
sulted. Only articles defining MOF according to the definition
of the Denver (18), Marshall (18, 19), or SOFA (20) score were
included in this review. A Denver score of more than 3 and a
Marshall score of more than 5, both for at least two consecutive
days, were used to define MOF. Furthermore, MOF according to
the SOFA score was defined as the simultaneous failure of two or
more organ systems. Organ failure was defined as a total of more
than two points in a single organ. Language was limited to English,
Dutch, or German. We reviewed the bibliographies of the eligible
studies for citations of additional suitable studies.
DATA SYNTHESIS
Primary outcomes were risk factors for TIC- and transfusion-
associated MOF. Since most of the studies in this field are observa-
tional studies, we performed a quality assessment according to the
Newcastle-Ottawa Scale (21). Characteristics of the studies exam-
ined included comparability of the study groups, methods used
to select study participants and determination of outcome vari-
ables. The quality of selection of patients in the included studies
was rated as good if they included severely injured trauma patients
and the control group was drawn from the same community as
the exposed cohort. The assessment of comparability of the studies
was based on the design and/or analysis used in the studies. Qual-
ity of outcome variables was determined by follow-up period and
<10% of patients lost-to-follow-up. The Cochrane Collaboration’s
tool for assessing the risk of bias was used to assess the quality of
RCTs (22). This tool was used to evaluate RCTs on seven specific
domains (sequence generation, allocation concealment, blinding
of participants and personnel, blinding of outcome assessment,
incomplete outcome data, selective reporting, and other sources
of bias). If the results of studies were contradicting, the quality
assessment was used to grade conclusions.
Review Manager (RevMan 5, The Nordic Cochrane Centre)
was used to combine findings of studies in a meta-analysis. Stud-
ies were pooled if homogeneity was considered by assessing study
population, intervention,and outcome. RevMan was used to deter-
mine homogeneity by the inverse variance method for a random
or fixed effects model. If homogeneity was not obtained studies
were excluded from meta-analysis. Heterogeneity was expressed
by I 2. An I 2 of >75% was considered as substantial heterogeneity.
Meta-analysis was performed on observational studies and RCTs,
in which data from observational studies and RCTs were not com-
bined in the same meta-analysis. For the outcome of interest, risk
ratios and 95% confidence intervals were used.
RESULTS
We identified 476 articles (PubMed 320, Embase 156) meeting
the inclusion criteria. Of these, seven duplicates were removed.
Reviewing of the bibliographies resulted in 11 additional articles.
The full texts of 114 articles were assessed for eligibility. An addi-
tional 64 reviews were excluded, bringing the total on 50 included
articles with a total sample size of 63,586 patients (Figure 1). Of the
50 included studies, 46 studies were observational cohort studies
and 4 were RCTs. The observational studies included 15 retrospec-
tive and 31 prospective studies. Sample size in these studies varied
between 19 and 20,288 patients with a median of 384 (IQR 135–
1217) patients. Two studies included a heterogeneous population
of intensive care patients, all other studies were restricted to trauma
patients. The score of the included studies on the Newcastle-
Ottawa scale ranged from 6 to 8 with a median of 7. The score
of the Cochrane Collaboration’s tool for assessing the risk of bias
ranged from 8 to 9 (Tables 1 and 2; Table S1 in Supplementary
Material).
RISK FACTORS FOR TIC-ASSOCIATED MOF
Eighteen studies reported the effect of TIC on the development
of MOF in trauma patients (Table 1). The presence of hypoco-
agulopathy on admission to the emergency department (ED) was
an independent risk factor for MOF (26, 30, 33, 35–39); how-
ever, studies could not be pooled due to substantial heterogeneity
(I 2= 90%, Figure 2). Hypocoagulopathy was defined by pro-
longation of coagulation parameters including PTT, INR, and
APTT and a decreased platelet count (26). Four studies reported
a decreased platelet count as an independent risk factor (23, 26,
41, 72). Of note, hypocoagulopathy was rare in patients with-
out persisting shock (73). Other risk factors for TIC-associated
MOF were activation of protein C, increased levels of fibrinolytic
markers (27, 36–39), and increased levels of extracellular histones
(37). Of note, these risk factors were reported in small study
numbers.
Taken together, after trauma, damaged endothelial cells and
extracellular histones activate protein C, which inhibits factor Va
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FIGURE 1 |The process of selecting studies suitable for inclusion.
and VIIa and leads to hyperfibrinolysis due to the consumption
of plasminogen activator inhibitor, with subsequent hypocoagu-
lopathy (37, 74–76).
Later in the course of events following trauma, patients tend to
develop a hypercoagulopathy as reported in 5 studies with a total
of 5581 patients. In these studies, an association between throm-
boembolic events, including disseminated intravascular coagula-
tion (DIC) and venous thromboembolism (VTE), and MOF was
reported (27, 28, 30, 32, 34). Pooling of data in a meta-analysis was
not possible due to differences in outcome measures.
RISK FACTORS FOR TRANSFUSION-ASSOCIATED MOF
We found 36 studies reporting an association between transfusion
and the development of MOF in trauma patients (Table 2).
Fluids
Six studies investigated the effect of the administration of crystal-
loids on MOF in trauma patients. The majority of studies reported
crystalloid administration within the first 24 h post-injury as a risk
factor for the development of MOF (36, 42, 67, 69, 70). Another
study showed a trend toward a lower incidence of MOF in patients
who were administered <1000 ml of fluids prior to arrival at the
hospital. Two studies did not find a relation between fluids and
MOF (53, 65). However, these two studies did not adjust for
confounders. Pooling of data could not be performed due to dif-
ference in outcome measures. However, it is likely that crystalloid
administration is an independent risk factor for MOF given that
the studies, which adjusted for confounders found an association
between the administration of crystalloids and MOF.
Blood products
The effect of the amount of RBCs administered on the devel-
opment of MOF in trauma patients was reported in 14 studies
(5, 6, 36, 41–43, 45, 46, 55, 56, 61, 66). There seems to be a
dose-dependent association between MOF and transfusion, as a
significant linear trend was found between the number of RBCs
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Table 1 | Description of included studies; risk factors forTIC-associated MOF.
Reference Design Origin Patients N Groups Risk factors for MOF Quality
Nuytinck et al. (23) Prospective Europe Trauma patients 71 ARDS/MOF Plasma elastase level 7/9
Non-ARDS/MOF Complement activation
Wudel et al. (24) Retrospective USA Trauma patients 92 Survivors No difference 7/9
Non-survivors
Sigurddson et al. (25) Prospective Asia Critically ill patients 21 Hemorrhagic shock Platelet activity and intestinal
platelet sequestration
7/9
controls
Waydhas et al. (26) Prospective Europe Trauma patients 133 MOF No difference in coagulopathy 7/9
Non-MOF Platelet count <180,000/µL
Gando et al. (27) Prospective Japan Trauma patients 58 DIC DIC 6/9
Non-DIC
Gando et al. (28) Prospective Japan Trauma patients 47 DIC Thrombomodulin level 6/9
Non-DIC DIC
Sauaia et al. (29) Retrospective USA Trauma patients 411 MOF Colloid administration 9/9
Non-MOF Lower platelet count
Longer prothrombin time
Gando et al. (30) Prospective Japan Trauma patients 136 SIRS for ≤2 days SIRS ≥3 days 6/9
SIRS for ≥3 days Platelet counts
Non-SIRS DIC
Raeburn et al. (31) Retrospective USA Trauma patients 77 Abdominal compartment
syndrome (ACS)
No difference 7/9
Newell et al. (32) Retrospective USA Trauma patients 1751 Normal VTE 7/9
Overweight
Obese
Morbidly obese
Maegele et al. (33) Retrospective Europe Trauma patients 8724 Coagulopathy Coagulopathy 7/9
Non-coagulopathy
Paffrath et al. (34) Retrospective Europe Trauma patients 7937 VTE VTE 7/9
Non-VTE
Nydam et al. (35) Retrospective USA Trauma patients 1415 Thrombocytopenia Thrombocytopenia 8/9
Non-thrombocytopenia
Brown et al. (36) Prospective USA Trauma patients 1877 Acute traumatic
coagulopathy
Activation of protein C 7/9
Non-acute traumatic
coagulopathy
Acute coagulopathy
Male versus female Transfusion requirements
Kutcher et al. (37) Prospective USA Trauma patients 132 High histone levels High histone level 7/9
Low histone levels
Cohen et al. (38) Prospective USA Trauma patients 203 – Higher levels of activated
protein C upon admission
8/9
Cole et al. (39) Prospective Europe Trauma patients 158 Infection PC depletion of PC and raised
PAP levels
7/9
Non-infection
Trentzsch et al. (40) Retrospective Europe Trauma patients 20,288 Male No difference in coagulopathy 8/9
Female
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Table 2 | Description of included studies; risk factors for transfusion-associated MOF.
Reference Design Origin Patients N Groups Risk factors for MOF Quality
Sauaia et al. (41) Retrospective USA Trauma patients 394 MOF >6 RBCs 8/9
Non-MOF
Lehmann et al. (42) Retrospective Europe Trauma patients 1112 MOF RBC administration 8/9
Non-MOF Crystalloids
Moore et al. (43) Prospective USA Trauma patients 513 MOF Blood transfusion
products
8/9
Non-MOF
Waydhas et al. (44) RCT Europe Trauma patients 40 ATIII placebo Placebo 8/10
Sauaia et al. (29) Retrospective USA Trauma patients 411 MOF Colloid administration 9/9
Non-MOF Lower platelet count
Longer prothrombin time
Zallen et al. (45) Prospective USA Trauma patients 63 MOF Number of and a 8/9
Non-MOF Age of blood units
Cryer et al. (46) Prospective USA Trauma patients 105 MOF >6 RBC units 8/9
Non-MOF
Ciesla et al. (6) Prospective USA Trauma patients 1344 MOF Blood products 8/9
Non-MOF Transfusion of >6 RBCs
Frink et al. (47) Prospective Europe Trauma patients 143 MOF Transfusion 7/9
Non-MOF
Bulger et al. (48) RCT USA Trauma patients 209 Hypertonic fluids No difference 9/10
Ringer solution
Sperry et al. (50) Prospective USA Trauma patients 415 FFP:PRBC≥1:1.50 A high FFP:PRBC ratio
patients
8/9
FFP:PRBC≤1:1.51
Maegele et al. (51) Retrospective Europe Trauma patients 713 RBC:FFP>1.1 RBC: FFP 0·9–1·1 (1:1) 8/9
RBC:FFP 0.9–1.1
RBC:FFP <0.9
Holcomb et al. (52) Retrospective USA Trauma patients 467 Low plasma:RBC<1:2 No difference 8/9
high plasma:RBC ratio >1:2
Low platelet:RBC<1:2
high platelet:RBC ratio >1:2
Jastrow et al. (53) Prospective USA Trauma patients 48 MOF Transfusion FFPs and
RBCs
7/9
Non-MOF
Englehart et al. (54) Prospective USA Trauma patients 1036 RBCs leukoreduced No difference 6/9
RBCs not leukoreduced
Dewar et al. (55) Retrospective USA Trauma patients 504 MOF No difference 7/9
Non-MOF
Mahambrey et al. (56) Retrospective Canada Trauma patients 260 – RBC administration 7/9
Watson et al. (57) Prospective USA Trauma patients 1175 High plasma transfusion FFP and cryoprecipitate 9/9
Low plasma transfusion
Boffard et al. (58) RCT Africa Trauma patients 301 rVIIa
Placebo
rVII group lower
incidence MOF although
not significant
8/10
Cotton et al. (59) Prospective USA Trauma patients 266 Pre-massive transfusion protocol Blood product
administration
7/9
Massive transfusion protocol
(Continued)
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Table 2 | Continued
Reference Design Origin Patients N Groups Risk factors for MOF Quality
Hauser et al. (60) RCT World wide Trauma patients 573 FVIIa
Placebo
A trend is observed
toward decreased MOF
in rFVIIa group
9/10
Paffrath et al. (34) Retrospective Europe Trauma patients 7937 VTE VTE 7/9
Non-VTE
Brattstrom et al. (5) Prospective Europe Trauma patients 164 – >10 RBC units 8/9
Johnson et al. (61) Retrospective USA Trauma patients 1440 MOF RBC administration 8/9
Non-MOF
Nienaber et al. (62) Retrospective Europe Trauma patients 36 FFP
Coagulation factor concentrates
PCC treatment
associated with
reduction of MOF
7/9
Perkins et al. (63) Retrospective USA Trauma patients 369 Fresh whole blood No difference 7/9
Apheresis platelets
Wafaisade et al. (64) Retrospective Europe Trauma patients 1362 FFP:RBC<1:1 No difference 7/9
FFP:RBC 1:1
FFP:RBC>1:1
Hussmann et al. (65) Retrospective Europe Trauma patients 375 <1000 ml Crystalloids <1000 ml 7/9
1000–2000 ml
2001–3000 ml
>3000 ml
Brakenridge et al. (66) Prospective USA Trauma patients 1366 – >10 RBC units 7/9
Borgman et al. (67) Retrospective Europe Trauma patients 2474 High FFP:RBC>1:2 No difference 8/9
Low FFP:RBC<1:2
Brown et al. (36) Prospective USA Trauma patients 1877 Acute traumatic coagulopathy Crystalloid, RBC, and FFP
administration
7/9
Non-acute traumatic coagulopathy
Innerhofer et al. (68) Prospective Europe Trauma patients 144 Fibrinogen and/or prothrombin
complex concentrate alone
FFP administration 8/9
Additionally FFP
Minei et al. (69) Prospective USA Trauma patients 916 MOF FFP administration 9/9
Non-MOF Crystalloid administration
Neal et al. (70) Prospective USA Trauma patients 452 Crystalloid:RBC ratio Crystalloid:RBC ratio
>1.5:1
9/9
Duchesne et al. (71) Retrospective USA Trauma patients 188 Hypertonic solution Isotonic solution 7/9
Isotonic solution
FIGURE 2 |The impact ofTIC on the development of MOF. Studies have reported an association between TIC and the incidence of MOF; however, pooling of
data was not possible due to substantial heterogeneity.
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transfused and the incidence of MOF (43, 49). In addition, most
studies reported an increased risk for MOF after administration
of more than six units; however, studies could not be pooled due
to differences in outcomes measures. Besides the amount of RBCs
administrated, the age of red blood cells of >14 days was found
as an independent risk factor in four studies. Storage of RBCs for
over 14 days was reported to increase the risk of MOF with an OR
of 1.16 (95% CI 1.02–1.32; P = 0.03). The OR increased to 1.22
(95% CI 1.06–1.41; P = 0.006) when the RBC units were older
than 21 days (45).
Eight studies investigated the effect of FFPs on the devel-
opment of MOF. Two studies observed a relation between the
administration of FFPs and MOF (57, 69). Other studies reported
merely a trend or results were not adjusted for confounders
(33, 36, 42, 50, 52, 53). When data of five observational studies
were pooled for meta-analysis, there was a significant association
between a high FFP:RBC ratio of ≥1:1 and MOF (RR 1.11, 95%
CI 1.04–1.19, Figure 3). Of note, studies were limited in design.
The effect of platelets on the development of MOF was investi-
gated in five studies. No significant association between platelet
administration and MOF was reported in these studies (52, 53,
57, 61, 63).
Procoagulant agents
Five studies reported on the relation between MOF and the use
of procoagulant agents in patients with severe hemorrhage. In an
RCT with 573 patients, recombinant factor VII (rVII) significantly
reduced transfusion requirements in both blunt and penetrat-
ing trauma patients and showed a trend toward a lower MOF
rate in blunt trauma patients (60). Another RCT showed a lower
incidence of MOF in patients treated with rVII, although these
results were not significant (58). Pooling of data from these two
RCTs suggested a lower incidence of MOF in patients treated with
rVII compared to placebo (RR 0.81, 95% CI 0.68–0.98, Figure 4).
The early and high-dose administration of antithrombin (AT)
significantly reduced duration of MOF, but did not reduce the
incidence of MOF (44). Of note, there was no significant differ-
ence in safety profile, including thromboembolic events, between
the groups. Two studies reported that prothrombin complex con-
centrate (PCC) administration resulted in decreased transfusion
requirements with an associated significant lower frequency of
MOF in severely injured trauma patients (62, 77).
In summary, the limitedly available data suggest that procoagu-
lant agents do not contribute to a higher incidence of thromboem-
bolic events and subsequently MOF in severe trauma patients.
In fact, these agents are associated with reduced transfusion
requirements and a reduced incidence of MOF.
DISCUSSION
Risk factors for TIC-associated MOF in severely injured trauma
patients are early hypocoagulopathy, whereas later in the course
after admission, the occurrence of thromboembolic events was
associated with MOF. Risk factors for transfusion-associated MOF
were the administration of fluids and red blood cell units, the age
of red blood cells and an FFP:RBC ratio ≥1:1. Risk factors are
summarized in Table 3.
Hemorrhagic shock and early presence of hypocoagulopa-
thy are risk factors for MOF in trauma patients. Subsequently,
after at least 24-h after admission, thromboembolic events were
reported as risk factors. Thereby, the coagulation profile asso-
ciated with MOF seems to change over time. In an effort to
reconcile these findings, we hypothesize that patients can transfer
FIGURE 3 | Meta-analysis: the impact of a high FFP:RBC ratio (≥1:1) versus a low FFP:RBC ratio (<1:1) on the development of MOF. A significant
association between a high FFP:RBC ratio and the incidence of MOF is observed (P =0.003).
FIGURE 4 | Meta-analysis: the effect of administration of rVII on the development of MOF. A significant lower incidence of MOF was observed in patients
with rVII compared to patients with placebo (P =0.03).
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from a hypocoagulable state on admission toward a hypercoag-
ulable state later during the hospital stay, which may predispose
to MOF. Immediately after tissue injury, thrombomodulin com-
plexes and extracellular histones activate protein C, which leads
to hypocoagulopathy due to the inhibition of FVa and FVII and
hyperfibrinolysis (28, 37, 74, 75). Activation of protein C results
in utilization of protein C. If protein C levels are consumed and
patients do not recover their protein C levels, inhibition of FVa
and VII will not occur, causing a hypercoagulable state. This may
be followed by the formation of vascular thrombi leading to cell
damage in organs and eventually MOF (Figure 5). Further studies
are required to confirm this hypothesis.
Risk factors for transfusion-associated MOF are administration
of crystalloids, transfusion of RBCs, the age of RBCs>14 days and
an FFP:RBC ratio ≥1:1. When transfusion of fluids and blood
products is inevitable a limited amount of fluid and blood prod-
ucts is recommended. We found that a high FFP:RBC ratio is
an independent risk factor for MOF. However, since transfusion
with a low FFP:RBC ratio of <1:1 is associated with a higher
Table 3 | Risk factors forTIC- and transfusion-associated MOF.
Trauma-induced coagulopathy
Hypocoagulpathy on emergency department (26, 30, 33, 35–39)
High activated protein C levels on emergency department (36, 38, 39)
High extracellular histones levels on emergency department (37)
Depleted PC levels during hospital stay (38)
Thromboembolic events, e.g., DIC and DVT during hospital stay (76, 78)
Transfusion strategy
Transfusion of RBCs, FFPs, and crystalloids within first 24 h post-injury
(6, 36, 41, 43, 45, 65)
Age RBC >2 weeks (45)
mortality due to bleeding (50, 51, 79, 80), clear recommendations
on the FFP:RBC ratio, with the aim to limit MOF cannot be made.
In particular, due to the different scoring systems used to define
MOF in the meta-analysis. Further studies on risks and benefits
of blood product ratios are warranted. A possible explanation for
the association between the administration of RBCs in trauma
patients and MOF may be storage time. However, the use of fresh
blood only is probably not feasible in exsanguinating trauma
patients. Furthermore, limited data in this study suggest that
procoagulant agents do not contribute to a higher incidence of
thromboembolic events and subsequently MOF in severely injured
trauma patients. In fact, they seem to reduce the risk of MOF,
which is most likely related to a decrease in transfusion require-
ments. Whether the addition of procoagulant agents may decrease
transfusion requirements and subsequently the development of
MOF remains to be determined.
LIMITATIONS
There are several limitations to this review. The included studies
have a considerable risk of bias related to design and method-
ology and several studies did not adjust for confounders. Also,
there was a relevant heterogeneity as data were presented as mean
or median, as frequencies and percentages, and as odds ratios
with 95% confidence intervals. This hampered pooling of data
in the meta-analysis. Pooling of data was feasible in 7 out of the
50 included studies. Additionally, we have used the Newcastle-
Ottawa Scale to assess the quality of observational studies. Previous
studies reported a low reliability of the scale due to differences
in assessment and low agreement between reviewers, which is a
limitation of the scale and subsequently of this study (81, 82).
However, despite these limitations, the Cochrane Collaboration
recommends the Newcastle-Ottawa scale as the most useful tool
for assessing the risk of bias in non-RCTs (83). Furthermore,
Consumpon protein C
Acvaon FVa and FVII
Tissue damage Bleeding Hemorrhagic shock
Extracellular histones
+
Thrombin-thrombomodulin
complexes
Acvaon protein C Hypocoagulopathy
Depleon protein C Hypercoagulopathy Thromboembolic events
MOF
VTE & DIC
Transfusion
Inhibion FVa and FVII
Depleon clo ng factors
Trauma
FIGURE 5 | Linking hypo- and hypercoagulopathy in the development of MOF in trauma patients; a hypothesis.
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there is a lack of a uniform definition of MOF. The use of dif-
ferent scores of MOF hampers interpretation of the results of the
meta-analyses and therefore no firm conclusions can be drawn.
Additional studies are required to confirm the results of this study.
CONCLUSION
Identifying patients at high risk for MOF may guide the need for
monitoring of organ failure and may provide avoidance of ther-
apy, which can aggravate organ failure. Early hypocoagulopathy
and shock are risk factors for TIC-associated MOF in severely
injured trauma patients. Later in the course of trauma, a hyper-
coagulable state with the occurrence of thromboembolic events
predisposes to MOF. Risk factors for transfusion-associated MOF
include the administration of crystalloids and red blood cells and a
prolonged storage time of red blood cells. However, pooling of data
was hampered by heterogeneity of the study populations and out-
come measures. Future prospective studies investigating TIC- and
transfusion-associated risk factors on late outcome are required.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online at
http://journal.frontiersin.org/article/10.3389/fmed.2015.00024/
abstract
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